DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
GSK2269557
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK2269557
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISUZINAXIB HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
ISUZINAXIB HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C17H18ClN3O
Molecular Weight:
315.8
AlogP:
3.59
PSA:
50.94
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ZATOLMILAST
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Fragile X Syndrome
Phosphodiesterase 4D inhibitor
ZATOLMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
G786V328X6
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClF3NO2
Molecular Weight:
405.8
AlogP:
5.64
PSA:
50.19
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LANICEMINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Major
Glutamate [NMDA] receptor blocker
LANICEMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
9TMU325RK3
Molecule Type:
Small molecule
Molecular Formula:
C13H14N2
Molecular Weight:
198.27
AlogP:
2.32
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
HT-0712
2
Small molecule
Investigational
Unknown
Unknown
Memory Disorders; Rhinitis, Allergic, Seasonal
Phosphodiesterase 4 inhibitor
HT-0712
×
Maximum Phase:
2
First Approval:
None
UNII:
2O43FXG9IG
Molecule Type:
Small molecule
Molecular Formula:
C25H31NO3
Molecular Weight:
393.53
AlogP:
4.79
PSA:
47.56
HBD:
1.0
HBA:
#RotB:
6.0
Source:
OBI-3424
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute
DNA cross-linking agent
OBI-3424
×
Maximum Phase:
2
First Approval:
None
UNII:
X6SH5T8H76
Molecule Type:
Small molecule
Molecular Formula:
C21H25N4O6P
Molecular Weight:
460.43
AlogP:
3.91
PSA:
105.0
HBD:
0.0
HBA:
#RotB:
9.0
Source:
RADAFAXINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
RADAFAXINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Q47741214K
Molecule Type:
Small molecule
Molecular Formula:
C13H18ClNO2
Molecular Weight:
255.74
AlogP:
2.27
PSA:
41.49
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TABIMORELIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Cytochrome P450 3A4 inhibitor
TABIMORELIN
×
Maximum Phase:
2
First Approval:
None
UNII:
L51CBE03KF
Molecule Type:
Small molecule
Molecular Formula:
C32H40N4O3
Molecular Weight:
528.7
AlogP:
3.71
PSA:
95.74
HBD:
2.0
HBA:
#RotB:
11.0
Source:
PIDOLIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PIDOLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
SZB83O1W42
Molecule Type:
Small molecule
Molecular Formula:
C5H7NO3
Molecular Weight:
129.12
AlogP:
-0.65
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
1.0
Source:
RILEMATOVIR
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Respiratory Syncytial Virus Infections; Infections
Fusion glycoprotein F0 inhibitor
RILEMATOVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
NQ99E8OH3P
Molecule Type:
Small molecule
Molecular Formula:
C21H20ClF3N4O3S
Molecular Weight:
500.93
AlogP:
3.85
PSA:
78.89
HBD:
0.0
HBA:
#RotB:
7.0
Source:
TOP-1288
2
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
TOP-1288
×
Maximum Phase:
2
First Approval:
None
UNII:
19ZTZ9YC4O
Molecule Type:
Small molecule
Molecular Formula:
C43H49N7O9S
Molecular Weight:
839.97
AlogP:
6.88
PSA:
200.36
HBD:
5.0
HBA:
#RotB:
19.0
Source:
DS-1001A
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DS-1001A
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H18Cl3FN2O4
Molecular Weight:
535.79
AlogP:
7.56
PSA:
85.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SRT-2104
2
Small molecule
Investigational
Unknown
Unknown
Atrophy; Colitis, Ulcerative; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive; Sepsis; Diabetes Mellitus, Type 2; Psoriasis
NAD-dependent deacetylase sirtuin 1 activator
SRT-2104
×
Maximum Phase:
2
First Approval:
None
UNII:
4521NR0J09
Molecule Type:
Small molecule
Molecular Formula:
C26H24N6O2S2
Molecular Weight:
516.65
AlogP:
4.97
PSA:
84.65
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TETRASUL
2
Small molecule
Investigational
Unknown
Unknown
Rosacea
Unknown
TETRASUL
×
Maximum Phase:
2
First Approval:
None
UNII:
BEO7JP5U0R
Molecule Type:
Small molecule
Molecular Formula:
C12H6Cl4S
Molecular Weight:
324.06
AlogP:
6.45
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
2.0
Source:
BUDIODARONE
2
Small molecule
Investigational
Unknown
Unknown
Atrial Fibrillation
Unknown
BUDIODARONE
×
Maximum Phase:
2
First Approval:
None
UNII:
F5Y53150C8
Molecule Type:
Small molecule
Molecular Formula:
C27H31I2NO5
Molecular Weight:
703.35
AlogP:
6.48
PSA:
68.98
HBD:
0.0
HBA:
#RotB:
12.0
Source:
EMERAMIDE
2
Small molecule
Investigational
Unknown
Unknown
beta-Thalassemia; Mercury Poisoning; Pulmonary Disease, Chronic Obstructive
Antioxidant and metal chelator
EMERAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
4U7K5X4ANS
Molecule Type:
Small molecule
Molecular Formula:
C12H16N2O2S2
Molecular Weight:
284.41
AlogP:
1.01
PSA:
58.2
HBD:
4.0
HBA:
#RotB:
6.0
Source:
13-DEOXYDOXORUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
13-DEOXYDOXORUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
1S9VO1DQG5
Molecule Type:
Small molecule
Molecular Formula:
C27H31NO10
Molecular Weight:
529.54
AlogP:
0.82
PSA:
189.0
HBD:
6.0
HBA:
#RotB:
5.0
Source:
POLYCARBOPHIL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Bulk forming laxative
POLYCARBOPHIL
×
Maximum Phase:
2
First Approval:
None
UNII:
W25LM17A4W
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIRAPARIB TOSYLATE MONOHYDRATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NIRAPARIB TOSYLATE MONOHYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OROTIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
OROTIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
61H4T033E5
Molecule Type:
Small molecule
Molecular Formula:
C5H4N2O4
Molecular Weight:
156.1
AlogP:
-1.24
PSA:
103.02
HBD:
3.0
HBA:
#RotB:
1.0
Source:
ASLAN-003
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Dihydroorotate dehydrogenase inhibitor
ASLAN-003
×
Maximum Phase:
2
First Approval:
None
UNII:
I58WE41H6X
Molecule Type:
Small molecule
Molecular Formula:
C19H14F2N2O3
Molecular Weight:
356.33
AlogP:
4.48
PSA:
71.45
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CENTHAQUINE
2
Small molecule
Investigational
Unknown
Unknown
Shock
Unknown
CENTHAQUINE
×
Maximum Phase:
2
First Approval:
None
UNII:
QD4VI0J9T5
Molecule Type:
Small molecule
Molecular Formula:
C22H25N3
Molecular Weight:
331.46
AlogP:
3.91
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
4.0
Source:
R-343
2
Small molecule
Investigational
Unknown
Unknown
Asthma
Tyrosine-protein kinase SYK inhibitor
R-343
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H17F3N6O4
Molecular Weight:
474.4
AlogP:
3.15
PSA:
126.5
HBD:
4.0
HBA:
#RotB:
7.0
Source:
DEXPRAMIPEXOLE DIHYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis
Unknown
DEXPRAMIPEXOLE DIHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
795J01AE70
Molecule Type:
Small molecule
Molecular Formula:
C10H21Cl2N3OS
Molecular Weight:
302.27
AlogP:
1.58
PSA:
50.94
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MANNOSE-6-PHOSPHATE
2
Small molecule
Investigational
Unknown
Unknown
Skin Abnormalities; Wounds and Injuries
Unknown
MANNOSE-6-PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
C77UQ006XD
Molecule Type:
Small molecule
Molecular Formula:
C6H13O9P
Molecular Weight:
260.13
AlogP:
-3.1
PSA:
156.91
HBD:
6.0
HBA:
#RotB:
3.0
Source:
SEPETAPROST
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SEPETAPROST
×
Maximum Phase:
2
First Approval:
None
UNII:
79O7855J4G
Molecule Type:
Small molecule
Molecular Formula:
C26H36F2O6
Molecular Weight:
482.56
AlogP:
4.17
PSA:
85.22
HBD:
2.0
HBA:
#RotB:
10.0
Source:
BMS-813160
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal; Hyperplasia; Diabetic Nephropathies; Neoplasms
C-C chemokine receptor type 2 antagonist
BMS-813160
×
Maximum Phase:
2
First Approval:
None
UNII:
83U7957287
Molecule Type:
Small molecule
Molecular Formula:
C25H40N8O2
Molecular Weight:
484.65
AlogP:
2.25
PSA:
116.55
HBD:
3.0
HBA:
#RotB:
5.0
Source:
DEOXYCYTIDINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms
Unknown
DEOXYCYTIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
0W860991D6
Molecule Type:
Small molecule
Molecular Formula:
C9H13N3O4
Molecular Weight:
227.22
AlogP:
-1.53
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GSK2798745
2
Small molecule
Investigational
Unknown
Unknown
Cough; Macular Edema; Heart Failure; Pulmonary Edema
Transient receptor potential cation channel subfamily V member 4 antagonist
GSK2798745
×
Maximum Phase:
2
First Approval:
None
UNII:
63FJ7LF55O
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AFP-464
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms
Unknown
AFP-464
×
Maximum Phase:
2
First Approval:
None
UNII:
73JNH95XPX
Molecule Type:
Small molecule
Molecular Formula:
C26H35F3N4O9S2
Molecular Weight:
668.71
AlogP:
3.94
PSA:
137.37
HBD:
4.0
HBA:
#RotB:
9.0
Source:
IFIDANCITINIB
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic
Unknown
IFIDANCITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
R105E71J13
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN5O3
Molecular Weight:
395.39
AlogP:
4.16
PSA:
105.07
HBD:
3.0
HBA:
#RotB:
5.0
Source:
SISUNATOVIR
2
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Fusion glycoprotein F0 inhibitor
SISUNATOVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
KE63TTO7WK
Molecule Type:
Small molecule
Molecular Formula:
C23H22F4N4O
Molecular Weight:
446.45
AlogP:
4.56
PSA:
64.15
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD-7624
2
Small molecule
Investigational
Unknown
Unknown
Inflammation; Asthma; Pulmonary Disease, Chronic Obstructive
MAP kinase p38 alpha inhibitor
AZD-7624
×
Maximum Phase:
2
First Approval:
None
UNII:
3P4CR02JTD
Molecule Type:
Small molecule
Molecular Formula:
C25H22N2O
Molecular Weight:
366.46
AlogP:
5.78
PSA:
41.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TANSHINONE IIA SULFONATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TANSHINONE IIA SULFONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5CKR8JG9OW
Molecule Type:
Small molecule
Molecular Formula:
C19H17NaO6S
Molecular Weight:
396.4
AlogP:
3.49
PSA:
101.65
HBD:
1.0
HBA:
#RotB:
1.0
Source:
Q203
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
Q203
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
97
98
99
100
101
102
103
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA